BSE filing, NSE: GOYALASS. Summary written from the filing by ALFA Finder's alert engine.
Goyal Associates Ltd: key numbers
- Share price
- ₹1.26
- Market cap
- ₹6.67 Cr
- Revenue (annual)
- ₹1.24 Cr
- Net profit (annual)
- ₹-0.27 Cr
- P/E (TTM)
- -116.2×Sector 19.7×
- Promoter holding
- 4.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Goyal Associates Ltd
All →Goyal Associates Fund Raise of ₹70 Cr
Goyal Associates' board approved a rights issue of equity shares up to Rs.70 Crore. The board also noted a director's resignation and approved a CFO change.
- Value
- ₹70.00 Cr
Goyal Associates Annual General Meeting
Goyal Associates held its 32nd AGM on October 24, 2026 via VC/OAVM. Agenda covered accounts, MD and director appointments, and capital increase; voting results are pending.
Goyal Associates Other Announcement
Goyal Associates Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Goyal Associates Board Meeting Date
Goyal Associates will hold a board meeting on October 24, 2026, to consider a proposal for raising funds through various equity or debt instruments.
Goyal Associates Management Change
Mr. Vuppala Naga Malleswara Rao has resigned as a Non-Executive Non-Independent Director of Goyal Associates Limited. His resignation is effective from October 16, 2026.
Goyal Associates Annual Report
Goyal Associates Limited has filed its 32nd Annual Report for the Financial Year 2025-26, including the notice for the upcoming 32nd Annual General Meeting.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.